OmniSonics Appoints J. Daniel Cole Chairman of...( WILMINGTON Mass. Sept. 24 /- Omni...)
| HOME >> BIOLOGY >> TECHNOLOGY |
WILMINGTON, Mass., Sept. 24 /PRNewswire/ -- OmniSonics Medical Technologies, Inc., a leading developer of advanced medical devices for occlusive vascular disease, today announced the appointment of J. Daniel Cole as the company's new Chairman of the Board.
Mr. Cole is a founding partner with Spray Venture Partners, a venture capital firm that focuses exclusively on emerging healthcare technology companies. He brings twenty years of medical device operational experience, having served on the boards of 10 companies, two of which he started. Prior to joining Spray, Mr. Cole served as senior vice president and group president of Boston Scientific Corporation's (BSC) vascular business, a $1.2 billion group, and was also responsible for BSC's international operations. Prior to BSC, he was president and chief iperating officer of SCIMED Life Systems before the company's merger with Boston Scientific. He also held a variety of executive and general management positions at Baxter Healthcare. He currently serves on the Board of Directors of Acorn Cardiovascular, Tryton Medical, Direct Flow Medical, and Tremont Medical, and is actively involved in Kolis Scientific, PneumRx, and Thoratec Laboratories.
"We are thrilled to have Dan Cole as our new Chairman of the Board for OmniSonics," said Richard Ganz, president and CEO, OmniSonics Medical Technologies. "Over the last few years, we have been actively building a world-class team with in-depth experience in product development and commercialization. Dan's experience and leadership will be a major asset as we launch our products for vascular occlusive disease and build a word-class commercial enterprise."
"This is an exciting time to join the OmniSonics team," said J. Daniel
Cole, Chairman of the Board and partner at Spray Venture Partners. "The
company has assembled a management team with over 80 cumulative years of
experience in medical devices and commercial operations. They have
developed breakthrough
'/>"/>
| SOURCE OmniSonics Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |